These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30753806)

  • 1. [Schizophrenia: What Non-Psychiatrist Physicians Need to Know].
    Queirós T; Coelho F; Linhares L; Telles-Correia D
    Acta Med Port; 2019 Feb; 32(1):70-77. PubMed ID: 30753806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness.
    Haas GL; Garratt LS; Sweeney JA
    J Psychiatr Res; 1998; 32(3-4):151-9. PubMed ID: 9793868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are schizophrenic patients being told their diagnosis today in France?].
    Villani M; Kovess-Masféty V
    Encephale; 2017 Apr; 43(2):160-169. PubMed ID: 27372353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
    Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
    Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical diagnosis and drug therapy of elderly patients with schizophrenia : A restrospective analysis of data in a department of old age psychiatry].
    Jagsch C; Dietmaier G; Jagsch M; Kurz M
    Neuropsychiatr; 2016 Jun; 30(2):74-81. PubMed ID: 27294270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relapse in schizophrenia: an exploratory study of the joint conceptions of patients, parents and caregivers].
    Koenig M; Castillo MC; Urdapilleta I; Le Borgne P; Bouleau JH
    Encephale; 2011 Jun; 37(3):207-16. PubMed ID: 21703436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with schizophrenia: clinical picture and pharmacological treatment.
    Masi G; Mucci M; Pari C
    CNS Drugs; 2006; 20(10):841-66. PubMed ID: 16999454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Schizophrenics in the doctor's office. Diagnostic and therapeutic aspects].
    Bottlender R; Möller HJ
    MMW Fortschr Med; 2004 May; 146 Spec No 2():19-23. PubMed ID: 15376697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Dec; 34(6):597-605. PubMed ID: 19081457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic treatment of the psychotic symptoms in schizophrenia].
    Goldchluk A
    Vertex; 2002; 13 Suppl 1():4-11. PubMed ID: 12122421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on early intervention in schizophrenia.
    Dyer JG; McGuinness TM
    J Psychosoc Nurs Ment Health Serv; 2008 Jun; 46(6):19-22. PubMed ID: 18595455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the prodromal progression of schizophrenia that influence the course of the illness.
    Bota RG; Sagduyu K; Munro JS
    CNS Spectr; 2005 Dec; 10(12):937-42. PubMed ID: 16344830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.